Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old

European Respiratory Journal

Volumn 48, Issue 1, 2016, Pages 179-186

  Raghu, Ganesh ^a   Chen, Shih Yin ^b   Hou, Qiang ^b   Yeh, Wei Shi ^b   Collard, Harold R ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BIOGEN   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; BRONCHIOLITIS; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; FATIGUE; FEMALE; FIBROSING ALVEOLITIS; GASTROESOPHAGEAL REFLUX; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; TREND STUDY; UNITED STATES; ADOLESCENT; ALGORITHM; COMORBIDITY; FACTUAL DATABASE; INTERNATIONAL CLASSIFICATION OF DISEASES; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SEX RATIO; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALGORITHMS; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; UNITED STATES; YOUNG ADULT;

EID: 84977104385     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01653-2015     Document Type: Article

References (20)

1. Meltzer EB, Noble PW. Idiopathic pulmonary fibrosis. Orphanet J Rare Dis 2008; 3: 8.
2. Michaelson JE, Aguayo SM, Roman J. Idiopathic pulmonary fibrosis: a practical approach for diagnosis and management. Chest 2000; 118: 788-794.
3. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
4. Collard HR, King TE Jr, Bartelson BB, et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168: 538-542.
5. Fernandez Perez ER, Daniels CE, Schroeder DR, et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest 2010; 137: 129-137.
6. King TE Jr, Tooze JA, Schwarz MI, et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164: 1171-1181.
7. Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003; 168: 531-537.
8. Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011; 183: 431-440.
9. Raghu G, Chen SY, Yeh WS, et al. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. Lancet Respir Med 2014; 2: 566-572.
10. Hutchinson J, Fogarty A, Hubbard R, et al. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J 2015; 46: 795-806.
11. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011; 378: 1949-1961.
12. Martinez FJ, Safrin S, Weycker D, et al. The cliical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005; 142: 963-967.
13. King TE Jr, Albera C, Bradford WZ, et al. All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials. Am J Respir Crit Care Med 2014; 189: 825-831.
14. Samet JM, Coultas D, Raghu G. Idiopathic pulmonary fibrosis: tracking the true occurrence is challenging. Eur Respir J 2015; 46: 604-606.
15. Coultas DB, Zumwalt RE, Black WC, et al. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150: 967-972.
16. Raghu G, Weycker D, Edelsberg J, et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174: 810-816.
17. Esposito DB, Lanes S, Donneyong M, et al. Idiopathic pulmonary fibrosis in US automated claims: incidence, prevalence and algorithm validation. Am J Respir Crit Care Med 2015; 192: 1200-1207.
18. Collard HR, Chen SY, Yeh WS, et al. Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older. Ann Am Thorac Soc 2015; 12: 981-987.
19. Collard HR, Ward AJ, Lanes S, et al. Burden of illness in idiopathic pulmonary fibrosis. J Med Econ 2012; 15: 829-835.
20. Wu N, Yu YF, Chuang CC, et al. Healthcare resource utilization among patients diagnosed with idiopathic pulmonary fibrosis in the United States. J Med Econ 2015; 18: 249-257.